#ExistRefRangeSet>
Reference Interval:
#ExistRefRangeTable> | | Unexposed non-tobacco user
| Passive exposure
| Abstinent user for greater than 2 weeks
| Active tobacco product use
| | Nicotine
| Less than 2 ng/mL
| Less than 20 ng/mL
| Less than 30 ng/mL
| 1000-5000 ng/mL
| | Cotinine
| Less than 5 ng/mL
| Less than 20 ng/mL
| Less than 50 ng/mL
| 1000-8000 ng/mL
| | 3-OH-Cotinine
| Less than 50 ng/mL
| Less than 50 ng/mL
| Less than 120 ng/mL
| 3000-25000 ng/mL
| | Nornicotine
| Less than 2 ng/mL
| Less than 2 ng/mL
| Less than 2 ng/mL
| 30-900 ng/mL
| | Anabasine
| Less than 3 ng/mL
| Less than 3 ng/mL
| Less than 3 ng/mL
| 3-500 ng/mL*
| |
*ExistRefRangeTable>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
For medical purposes only; not valid for forensic use.
See Compliance Statement B: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
83887
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
3-Hydroxycotinine (Nicotine & Metabolites, Urine), Anabasine (Nicotine & Metabolites, Urine), Cotinine (Nicotine & Metabolites, Urine), Nicotine and Cotinine, LC/MS/MS, Urine (Nicotine & Metabolites, Urine), Nornicotine (Nicotine & Metabolites, Urine), Pain Management (Nicotine & Metabolites, Urine) |
*ExistCrossReferences>